Oscar Health, Inc. (OSCR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Oscar Health, Inc. (OSCR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 12, 2026, the Board of Directors (the “Board”) of Oscar Health, Inc. (the “Company”) appointed Messrs. Tomer C

Event · Exec change
Person
Tomer Cohen
Title
Board
Action
appointed
Effective
November 13, 2026
Also in this documentExec change · appointedExec change · appointed

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 16, 2026, 11:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$OSCR
Neutral
high confidence
Mentioned
$OSCR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OSCRNeutralLow
01

Why it matters

The filing provides the first public disclosure of three new directors and their compensation, a routine corporate governance event.

02

Market read

A standard governance filing with limited immediate trading impact; primarily of interest to shareholders and governance‑focused investors.

03

What to watch

Potential future impact of new board members' expertise in AI and payments on product roadmap.

Relevance 6/10Novelty 6/10Timing: after market close 2026-11-16

Background

Oscar Health is a U.S. health‑insurance technology company that regularly files 8‑K updates for board changes.

Company-level read

Ticker impact

$OSCRNeutralHigh confidence
Context

OSCR filed an 8‑K announcing the appointment of three new independent directors and their compensation arrangements.

Expected impact

minimal pressure or flat as market digests governance change

Evidence & confidence

Governance updates are routine; no immediate financial impact disclosed.

Market effects

None significant; health‑tech sector unchanged.

U.S. market only, no broader regional effect.

Limited to investors tracking Oscar Health governance.

Counterpoint

If investors view new directors as a signal of strategic shift, a modest upside could emerge.

Key entities

  • Oscar Health, Inc.

    U.S. listed health‑tech insurer (ticker OSCR).

  • Tomer Cohen

    New board member, former LinkedIn senior VP.

  • Eric Larsen

    New board member, healthcare private‑equity veteran.

  • Rajat Taneja

    New board member, former Visa technology executive.

Related articles

$UNHMed

Medicare, Medicaid Overhaul Targets Fraudulent Billing and Unauthorized Marketplace Enrollments

CMS proposed reforms to combat fraud in Medicare, Medicaid, CHIP, and the Health Insurance Marketplace, aiming to save $90B over 10 years. The rule strengthens oversight, requires self-reporting of overpayments, and increases transparency. Managed care stocks fell, including UNH, HUM, CVS, CLOV, CNC, MOH, ELV, and OSCR. Medicare anti-fraud efforts saved $41.9B in 2025, with a $22.30 return per dollar spent.

$OSCRHighAI 8/10

What Oscar Health (OSCR) Said on Its Q3 Earnings Call

Oscar Health (OSCR) reported Q3 improvements in medical loss ratio (84%) and SG&A expense ratio (14%). The company raised its 2026 outlook, expecting $850M-$950M in earnings from operations and $19B-$19.3B in revenue. Membership grew 27% YoY to 2.7M, but is expected to decline to 2.5M by year-end due to disenrollments. Oscar plans to expand its footprint and products for 2027.

$OSCRMed

Oscar Health Inc (OSCR) Q3 2026 Earnings Call Highlights: Record Profitability, Raised

Oscar Health (OSCR) reported Q3 2026 earnings with record profitability and raised guidance. Membership declined due to CMS reviews, with more disenrollments expected. Q4 SG&A expenses are projected to rise due to seasonal spending. CEO Mark Bertolini and CFO Richard Blackley discussed market share gains, utilization trends, and CMS program integrity initiatives. The company anticipates stable membership and market growth despite competitive pressures and regulatory uncertainties.

$OSCRHighAI 8/10

Oscar Health (OSCR) Q3 2026 Earnings Call Transcript

Oscar Health (OSCR) reported Q3 2026 revenue of $5.1B, up 70% YoY, with membership at 2.7M, up 27% YoY. Net income was $167.3M, reversing a prior-year loss. The company raised full-year guidance for revenue, earnings, and adjusted EBITDA. Management highlighted expansion into new markets, product launches, and operational efficiencies.

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.